Diabetes Care, Vol 20, Issue 6 1013-1018, Copyright © 1997 by American Diabetes Association

ARTICLES

Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycemia

P Perros, IJ Deary, RJ Sellar, JJ Best and BM Frier
Department of Diabetes, Royal Infirmary of Edinburgh, U.K.

OBJECTIVE: Previous studies of a cohort of 100 patients with IDDM have shown that a history of recurrent severe hypoglycemia is associated with a modest impairment of cognitive function. The aim of the present study was to determine whether IDDM patients with and without a history of severe hypoglycemia have lesions in the brain that are identifiable by magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) and to investigate the putative relationship of any structural brain abnormalities with cognitive function. RESEARCH DESIGN AND METHODS: MRI and MRS of the brain were performed in 22 patients from the original cohort. Eleven IDDM patients with no history of severe hypoglycemia (group A) were compared with 11 IDDM patients who had a history of five or more episodes of severe hypoglycemia (group B). RESULTS: Nine patients (41%) had abnormal scans. Two types of abnormalities were observed: high-intensity rounded lesions, > 3 mm in diameters, distributed in the periventricular white matter (leukoaraiosis) in four patients; and cortical atrophy in five patients. Five patients in group B had cortical atrophy, whereas no patient in group A demonstrated this feature (P < 0.05). MRS of the frontal and parietal lobes showed no differences in the N-acetyl aspartate/creatine or N-acetyl aspartate/choline ratios between groups A and B. Patients with cortical atrophy showed a nonsignificant trend toward reduced performance on Rapid Visual Information Processing. CONCLUSIONS: Brain abnormalities demonstrated by MRI are common in patients with IDDM of long duration and are suggestive of premature aging of the brain. IDDM per se may be an important pathogenic factor, but a significant association was observed between a history of recurrent severe hypoglycemia and cortical atrophy, which may be related to the modest impairment of cognitive function that has been reported previously.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. T. Kodl and E. R. Seaquist Cognitive Dysfunction and Diabetes Mellitus Endocr. Rev., June 1, 2008; 29(4): 494 - 511. [Abstract] [Full Text] [PDF]

				G. Musen, D. C. Simonson, N. R. Bolo, A. Driscoll, K. Weinger, A. Raji, J. Theberge, P. F. Renshaw, and A. M. Jacobson Regional Brain Activation during Hypoglycemia in Type 1 Diabetes J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1450 - 1457. [Abstract] [Full Text] [PDF]

				The Diabetes Control and Complications Trial/Epide Long-Term Effect of Diabetes and Its Treatment on Cognitive Function N. Engl. J. Med., May 3, 2007; 356(18): 1842 - 1852. [Abstract] [Full Text] [PDF]

				A. M.A. Brands, R. P.C. Kessels, R. P.L.M. Hoogma, J. M.L. Henselmans, J. W. van der Beek Boter, L. J. Kappelle, E. H.F. de Haan, and G. J. Biessels Cognitive Performance, Psychological Well-Being, and Brain Magnetic Resonance Imaging in Older Patients With Type 1 Diabetes Diabetes, June 1, 2006; 55(6): 1800 - 1806. [Abstract] [Full Text] [PDF]

				G. Musen, I. K. Lyoo, C. R. Sparks, K. Weinger, J. Hwang, C. M. Ryan, D. C. Jimerson, J. Hennen, P. F. Renshaw, and A. M. Jacobson Effects of Type 1 Diabetes on Gray Matter Density as Measured by Voxel-Based Morphometry Diabetes, February 1, 2006; 55(2): 326 - 333. [Abstract] [Full Text] [PDF]

				A. M. Wessels, S. A.R.B. Rombouts, S. Simsek, J. P.A. Kuijer, P. J. Kostense, F. Barkhof, P. Scheltens, F. J. Snoek, and R. J. Heine Microvascular Disease in Type 1 Diabetes Alters Brain Activation: A Functional Magnetic Resonance Imaging Study Diabetes, February 1, 2006; 55(2): 334 - 340. [Abstract] [Full Text] [PDF]

				D. Rankins, R. M. Wellard, F. Cameron, C. McDonnell, and E. Northam The Impact of Acute Hypoglycemia on Neuropsychological and Neurometabolite Profiles in Children With Type 1 Diabetes Diabetes Care, November 1, 2005; 28(11): 2771 - 2773. [Full Text] [PDF]

				R. Schmidt, L. J. Launer, L.-G. Nilsson, A. Pajak, S. Sans, K. Berger, M. M. Breteler, M. de Ridder, C. Dufouil, R. Fuhrer, et al. Magnetic Resonance Imaging of the Brain in Diabetes: The Cardiovascular Determinants of Dementia (CASCADE) Study Diabetes, March 1, 2004; 53(3): 687 - 692. [Abstract] [Full Text] [PDF]

				S. C. Ferguson, A. Blane, P. Perros, R. J. McCrimmon, J. J.K. Best, J. Wardlaw, I. J. Deary, and B. M. Frier Cognitive Ability and Brain Structure in Type 1 Diabetes: Relation to Microangiopathy and Preceding Severe Hypoglycemia Diabetes, January 1, 2003; 52(1): 149 - 156. [Abstract] [Full Text] [PDF]

				T. Y. Wong, R. Klein, A. R. Sharrett, D. J. Couper, B. E. K. Klein, D.-P. Liao, L. D. Hubbard, T. H. Mosley, and for the ARIC Investigators Cerebral White Matter Lesions, Retinopathy, and Incident Clinical Stroke JAMA, July 3, 2002; 288(1): 67 - 74. [Abstract] [Full Text] [PDF]

				D. E. Kim, S. H. Park, S. K. Kim, H. W. Nam, Y. S. Lee, J- K. Chung, and J. K. Roh Hypoglycemia-induced cerebellar dysfunction and quantitative positron emission tomography study Neurology, August 8, 2000; 55(3): 418 - 422. [Abstract] [Full Text] [PDF]